arginine and Carcinoma, Transitional Cell

arginine has been researched along with Carcinoma, Transitional Cell in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-199012 (85.71)18.7374
1990's1 (7.14)18.2507
2000's1 (7.14)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andreesen, R; Konur, A; Krause, SW; Kreutz, M; Rehli, M1
Furihata, M; Kurabayashi, A; Kuwahara, M; Matsumoto, M; Ohtsuki, Y; Shuin, T; Takeuchi, T; Terao, N1
Dalesio, O; Glashan, R; Green, DF; Newling, D; Robinson, MR; Smith, PH1
Lum, BL; Torti, FM1
de Pauw, M; Fosså, SD; Mulder, JH; Stoter, G; van Oosterom, AT1
Soloway, MS1
Dalesio, O; de Pauw, M; Denis, L; Robinson, M; Schulman, CC; Smith, P; Sylvester, R; Viggiano, G1
Elson, P; Khandekar, JD; Qazi, R1
Carbone, A; Carmignani, G; Dal Bo, V; Francini, M; Lo Re, G; Magri, MD; Merlo, A; Morassut, S; Talamini, R; Veronesi, A1
Carbone, A; Dal Bo, V; Francini, M; Monfardini, S; Veronesi, A1
Aso, Y; Fukushima, M; Matsuura, O; Naide, Y; Ohshima, S; Ono, Y; Ota, K; Suzuki, K; Tajima, A; Ushiyama, T1
Dal Bo, V; Francini, M; Galligioni, E; Lo Re, G; Merlo, A; Monfardini, S; Saracchini, S; Sorio, R; Veronesi, A1
Berenberg, J; Blumenstein, BA; Bukowski, RM; Johnson, K; O'Bryan, RM; Oishi, N; Quagliana, J; Rivkin, SE; Saiers, JH; Stephens, RL1
Frommhold, H; Jakse, G; zur Nedden, D1

Reviews

2 review(s) available for arginine and Carcinoma, Transitional Cell

ArticleYear
The biology and treatment of superficial bladder cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1984, Volume: 2, Issue:5

    Topics: Adenocarcinoma; Aged; Antineoplastic Agents; BCG Vaccine; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Combined Modality Therapy; Cystoscopy; Doxorubicin; Ethoglucid; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Prognosis; Teniposide; Thiotepa; Urinary Bladder; Urinary Bladder Neoplasms

1984
Rationale for intensive intravesical chemotherapy for superficial bladder cancer.
    The Journal of urology, 1980, Volume: 123, Issue:4

    Topics: Animals; Antineoplastic Agents; BCG Vaccine; Carcinoma, Transitional Cell; Doxorubicin; Humans; Mitomycins; Neoplasm Recurrence, Local; Neoplasm Seeding; Neoplasms, Experimental; Teniposide; Thiotepa; Urinary Bladder Neoplasms

1980

Trials

1 trial(s) available for arginine and Carcinoma, Transitional Cell

ArticleYear
Prophylactic chemotherapy of superficial transitional cell bladder carcinoma: an EORTC randomized trial comparing thiotepa, an epipodophyllotoxin (VM26) and TUR alone.
    European urology, 1982, Volume: 8, Issue:4

    Topics: Carcinoma, Transitional Cell; Clinical Trials as Topic; Follow-Up Studies; Humans; Neoplasm Recurrence, Local; Podophyllotoxin; Random Allocation; Teniposide; Thiotepa; Urinary Bladder Neoplasms

1982

Other Studies

11 other study(ies) available for arginine and Carcinoma, Transitional Cell

ArticleYear
Human monocytes induce a carcinoma cell line to secrete high amounts of nitric oxide.
    Journal of immunology (Baltimore, Md. : 1950), 1996, Sep-01, Volume: 157, Issue:5

    Topics: Arginine; Carcinoma, Transitional Cell; Coculture Techniques; Drug Combinations; Humans; Interleukin-1; Kidney Medulla; Leucine; Macrophage Activation; Monocytes; Nitric Oxide; Nitric Oxide Synthase; Nitrites; omega-N-Methylarginine; Solubility; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Urinary Bladder Neoplasms

1996
p53 mutation arising in Arg72 allele in the tumorigenesis and development of carcinoma of the urinary tract.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2002, Volume: 8, Issue:5

    Topics: Aged; Aged, 80 and over; Alleles; Amino Acid Substitution; Arginine; Base Sequence; Carcinoma, Transitional Cell; Codon; DNA Mutational Analysis; DNA, Neoplasm; Female; Genotype; Humans; Loss of Heterozygosity; Male; Middle Aged; Mutation; Polymorphism, Genetic; Tumor Suppressor Protein p53; Urologic Neoplasms

2002
Does intravesical chemotherapy prevent invasive bladder cancer?
    The Journal of urology, 1984, Volume: 131, Issue:1

    Topics: Administration, Topical; Aged; Antineoplastic Agents; Carcinoma, Transitional Cell; Follow-Up Studies; Humans; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Random Allocation; Teniposide; Thiotepa; Urinary Bladder Neoplasms

1984
Combination chemotherapy with cisplatin and VM-26 in advanced transitional cell carcinoma of the bladder.
    European journal of cancer & clinical oncology, 1984, Volume: 20, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Teniposide; Urinary Bladder Neoplasms

1984
Phase II evaluation of VM-26 in patients with metastatic transitional cell carcinoma of the urinary tract: an Eastern Cooperative Oncology Group study.
    Cancer treatment reports, 1982, Volume: 66, Issue:2

    Topics: Aged; Carcinoma, Transitional Cell; Drug Evaluation; Female; Humans; Leukopenia; Male; Middle Aged; Neoplasm Metastasis; Podophyllotoxin; Teniposide; Urologic Neoplasms

1982
Presurgery chemotherapy (CT) in locally advanced bladder carcinoma: a feasible and possibly effective approach.
    Medical oncology and tumor pharmacotherapy, 1989, Volume: 6, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Preoperative Care; Prospective Studies; Remission Induction; Teniposide; Tomography, X-Ray Computed; Urinary Bladder Neoplasms

1989
Pre surgery chemotherapy in bladder cancer.
    Progress in clinical and biological research, 1988, Volume: 260

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Preoperative Care; Teniposide; Urinary Bladder Neoplasms

1988
[Use of VM-26 as a single agent in the treatment of transitional cell carcinoma of the urinary tract].
    Nihon Gan Chiryo Gakkai shi, 1988, May-20, Volume: 23, Issue:5

    Topics: Adult; Aged; Carcinoma, Transitional Cell; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Podophyllotoxin; Teniposide; Ureteral Neoplasms; Urinary Bladder Neoplasms

1988
Combination chemotherapy with fluorouracil, adriamycin, cis-platinum and VM-26 in advanced transitional cell carcinoma of the urinary tract.
    European journal of cancer & clinical oncology, 1986, Volume: 22, Issue:12

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Drug Evaluation; Female; Fluorouracil; Humans; Male; Middle Aged; Teniposide; Urologic Neoplasms

1986
Teniposide in metastatic renal and bladder cancer: a Southwest Oncology Group Study.
    Cancer treatment reports, 1987, Volume: 71, Issue:12

    Topics: Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Female; Humans; Kidney Neoplasms; Male; Podophyllotoxin; Teniposide; Urinary Bladder Neoplasms

1987
Combined radiation and chemotherapy for locally advanced transitional cell carcinoma of the urinary bladder.
    Cancer, 1985, Apr-15, Volume: 55, Issue:8

    Topics: Aged; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Teniposide; Tomography, X-Ray Computed; Urinary Bladder Neoplasms

1985